Skip to main content

Ultimovacs ASA: Notification of major holdings

Written by Customer Service on . Posted in Public Companies.

Oslo, 9 January 2025: Reference is made to the stock exchange notices published by Ultimovacs ASA (the “Company“) on (i) 17 December 2024 regarding the contemplated business combination between the Company and Zelluna Immunotherapy AS (the “Business Combination“) and the fully committed private placement with gross proceeds of approx. NOK 51.7 million (the “Private Placement“) and (ii) today on 9 January 2025 regarding the approval by an extraordinary general meeting of the Company (the “EGM“) of relevant resolutions related to the Business Combination and the Private Placement. The Business Combination and the Private Placement are hereinafter referred to as the “Transactions“.

Following the EGM’s resolutions to approve the issuance of 167,864,598 shares in aggregate through the Transactions, and subject to completion of the Transactions, certain of the Company’s and Zelluna Immunotherapy AS’ major shareholders will cross threshold for disclosure of shareholdings pursuant to Chapter 4 of the Norwegian Securities Trading Act as follows:

  • Geveran Trading Company Ltd. has been allocated 4,230,769 offer shares in the Company in the Private Placement and will receive 20,847,543 consideration shares in the Business Combination, increasing its shareholding from 0 shares and votes to 25,078,312 shares and votes (approx. 12.4%) in the Company after completion of the Transactions.
  • Radforsk has been allocated 1,038,461 offer shares in the Company in the Private Placement and will receive 22,156,490 consideration shares in the Business Combination, increasing its shareholdings from 1,519,263 shares and votes (approx. 4.4% as of the date hereof) to 24,714,214 shares and votes (approx. 12.2%) in the Company after completion of the Transactions.
  • Inven2 AS has been allocated 384,615 offer shares in the Company in the Private Placement and will receive 19,357,583 consideration shares in the Business Combination, increasing its shareholdings from 1,265,139 shares and votes (approx. 3.7% as of the date hereof) to 21,007,337 shares and votes (approx. 10.4%) in the Company after completion of the Transactions.
  • Gjelsten Holding AS has been allocated 3,653,846 offer shares in the Company in the Private Placement and will not receive any consideration shares in the Business Combination, thus decreasing its total percentage of shares as a result of the Transactions from 6,495,866 shares and votes (approx. 18.88% as of the date hereof) to 10,149,712 shares and votes (approx. 5.0%) in the Company after completion of the Transactions.
  • Takeda Ventures, Inc. will receive 12,389,348 consideration shares in the Business Combination, increasing its shareholdings from 0 shares and votes to 12,389,348 shares and votes (approx. 6.1%) in the Company after completion of the Transactions.
  • Birk Venture AS has been allocated 538,461 offer shares in the Company in the Private Placement and will receive 14,196,604 consideration shares in the Business Combination, increasing its shareholdings from 0 shares and votes to 14,735,065 shares and votes (approx. 7.3%) in the Company after completion of the Transactions.

This information is subject to the disclosure requirements pursuant to Section 4-2 the Norwegian Securities Trading Act.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.